ODDB.org: Open Drug Database

Swissmedic Registration	68797	Date of registration	03.02.2023
Company name	Stemline Therapeutics Switzerland GmbH	Revision date
		Valid until	02.02.2028
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.40.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Elzonris 1mg / ml	Konzentrat zur Herstellung einer Infusionslösung	Concentrate for infusion (Tagraxofuspum 1 mg/ml)	L01XX67

2025	©ywesee GmbH